Health
How worried should we be about blood clots linked to AstraZeneca, J&J vaccines? – Financial Post
ZURICH — International drug regulators have said the benefits of using COVID-19 vaccines developed by Johnson & Johnson and AstraZeneca outweigh risks as they…
Article content
ZURICH International drug regulators have said the benefits of using COVID-19 vaccines developed by Johnson & Johnson and AstraZeneca outweigh risks as they investigate reports of extremely rare, but potentially fatal blood clots.
Several EU countries have restricted their use.
Amid concerns that reports of rare side-effects could undermine vaccine confidence, experts have emphasized that clotting risks for both shots remain extremely low and the vaccines are highly effective in…
-
Business17 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
Noosa News15 hours agoQueensland government to set up $400m energy investment fund
-
Business11 hours agoAustralian rare earths companies trading at record levels as China tightens export controls
-
Business9 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?